Antiplatelet Therapy in Clinical Practice
1st Edition
Published on 11. November 1999
Book
Hardback
368 pages
978-1-85317-624-1 (ISBN)
Description
Antiplatelet agents have a powerful effect on subacute thrombosis after the placement of coronary stents. As adjunctive therapy to stent placement, they assist in the prevention of restenosis. Some clinicians are of the opinion that in a few years' time, antiplatelet agents will displace stenting and coronary angioplasty as the intervention of choice for coronary stenosis. The editors have assembled a great team of clinicians and researchers who are all experts with antiplatelet agents. This book is a practical and essential guide for all those working in interventional cardiology.
More details
Language
English
Place of publication
United Kingdom
Publishing group
Taylor & Francis Ltd
Target group
College/higher education
Professional and scholarly
Dimensions
Height: 246 mm
Width: 189 mm
Weight
1139 gr
ISBN-13
978-1-85317-624-1 (9781853176241)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Content
1. I Coagulation and Platelet Function: A Practical Guide to Blood Coagulation 2. The Physiology of Normal Platelet Function 3. Laboratory Assessment of Platelet Function 4. Inherited and Acquired Disorders of Platelet Function 5. II Antiplatelet Agents: Overview of Antiplatelet Agents 6. Aspirin and Persantine 7. Ticlopidine/Clopidogrel 8. ReoPro 9. Peptide/Peptidomimetic IIb/IIIa Blockers (iv) 10. Peptide/Peptidomimetic IIb/IIIa Blockers (Oral) 11. Other Miscellaneous Antiplatelet Agents 12. III Clinical Applications: Overview of the Clinical Applications of Antiplatelet Therapy 13. Cerebrovascular Disease/Stroke 14. Antiplatelet Therapy in the Peripheral Vascular System 15. Atrial Fibrillation 16. Interventional Cardiology 17. Acute Coronary Syndromes 18. IV Directions for the Future 19. Platelet GP IIb/IIIa Inhibitor - Device Synergy During Percutaneous Coronary Intervention 20. Drug/Drug Synergy 21. New Agents on the Horizon